Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Angiotensin II | 5 | 2021 | 97 | 2.090 |
Why?
|
| Myocytes, Cardiac | 3 | 2017 | 166 | 1.130 |
Why?
|
| AIDS Dementia Complex | 4 | 2015 | 102 | 1.050 |
Why?
|
| Insulin Receptor Substrate Proteins | 2 | 2017 | 20 | 1.020 |
Why?
|
| Receptor, Insulin | 2 | 2015 | 25 | 0.920 |
Why?
|
| Flow Cytometry | 6 | 2017 | 399 | 0.810 |
Why?
|
| Neuroblastoma | 1 | 2021 | 129 | 0.730 |
Why?
|
| Losartan | 2 | 2017 | 32 | 0.690 |
Why?
|
| Heart | 2 | 2012 | 180 | 0.680 |
Why?
|
| Spironolactone | 2 | 2010 | 39 | 0.660 |
Why?
|
| Pharmacology | 1 | 2017 | 5 | 0.600 |
Why?
|
| Immunoassay | 1 | 2017 | 61 | 0.560 |
Why?
|
| Glucose | 1 | 2017 | 230 | 0.530 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 260 | 0.520 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2017 | 421 | 0.490 |
Why?
|
| Insulin Resistance | 1 | 2015 | 184 | 0.430 |
Why?
|
| Fumarates | 1 | 2012 | 11 | 0.430 |
Why?
|
| Cognition Disorders | 1 | 2015 | 233 | 0.430 |
Why?
|
| Aldosterone | 2 | 2010 | 66 | 0.430 |
Why?
|
| Electrophysiological Phenomena | 1 | 2012 | 19 | 0.430 |
Why?
|
| Receptor, Angiotensin, Type 1 | 4 | 2017 | 23 | 0.420 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 57 | 0.410 |
Why?
|
| Amides | 1 | 2012 | 68 | 0.410 |
Why?
|
| Parasitemia | 1 | 2011 | 14 | 0.400 |
Why?
|
| Plasmodium berghei | 1 | 2011 | 30 | 0.390 |
Why?
|
| Staining and Labeling | 1 | 2011 | 105 | 0.390 |
Why?
|
| Erythrocytes | 1 | 2011 | 111 | 0.380 |
Why?
|
| Fluorescent Dyes | 1 | 2011 | 181 | 0.370 |
Why?
|
| Malaria | 1 | 2011 | 78 | 0.370 |
Why?
|
| Cell Size | 1 | 2010 | 44 | 0.370 |
Why?
|
| Angiotensinogen | 1 | 2009 | 5 | 0.340 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2009 | 9 | 0.340 |
Why?
|
| Renin | 1 | 2009 | 30 | 0.340 |
Why?
|
| Blood Pressure | 1 | 2012 | 646 | 0.330 |
Why?
|
| Renin-Angiotensin System | 1 | 2008 | 36 | 0.320 |
Why?
|
| Cathepsin B | 2 | 2022 | 26 | 0.320 |
Why?
|
| Calcium Signaling | 1 | 2008 | 101 | 0.300 |
Why?
|
| Animals | 9 | 2017 | 15081 | 0.260 |
Why?
|
| Heart Failure | 1 | 2008 | 235 | 0.250 |
Why?
|
| Cricetinae | 3 | 2010 | 238 | 0.250 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 448 | 0.240 |
Why?
|
| HIV Infections | 2 | 2022 | 2303 | 0.230 |
Why?
|
| Receptor, Cannabinoid, CB2 | 1 | 2022 | 32 | 0.200 |
Why?
|
| Cannabinoids | 1 | 2022 | 56 | 0.190 |
Why?
|
| HIV Seropositivity | 2 | 2013 | 190 | 0.190 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 85 | 0.190 |
Why?
|
| Hypertension | 2 | 2017 | 796 | 0.170 |
Why?
|
| Humans | 10 | 2022 | 37093 | 0.170 |
Why?
|
| Angiotensin II Type 1 Receptor Blockers | 2 | 2009 | 37 | 0.160 |
Why?
|
| Reactive Oxygen Species | 1 | 2021 | 461 | 0.160 |
Why?
|
| Macrophages | 1 | 2022 | 439 | 0.160 |
Why?
|
| Cardiomyopathies | 2 | 2009 | 56 | 0.150 |
Why?
|
| Cell Differentiation | 1 | 2021 | 587 | 0.150 |
Why?
|
| Rats | 2 | 2017 | 3483 | 0.150 |
Why?
|
| Retrospective Studies | 2 | 2015 | 2026 | 0.150 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2017 | 23 | 0.150 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 46 | 0.140 |
Why?
|
| History, 20th Century | 1 | 2017 | 117 | 0.140 |
Why?
|
| Catechin | 1 | 2016 | 31 | 0.140 |
Why?
|
| Neovascularization, Pathologic | 1 | 2017 | 127 | 0.140 |
Why?
|
| Stilbenes | 1 | 2016 | 44 | 0.130 |
Why?
|
| Quercetin | 1 | 2016 | 45 | 0.130 |
Why?
|
| Cells, Cultured | 2 | 2010 | 1518 | 0.130 |
Why?
|
| Cross-Sectional Studies | 2 | 2015 | 2721 | 0.130 |
Why?
|
| Breast Neoplasms | 2 | 2017 | 1502 | 0.130 |
Why?
|
| Breast | 1 | 2016 | 135 | 0.130 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2015 | 26 | 0.130 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2016 | 110 | 0.120 |
Why?
|
| Neuropsychological Tests | 2 | 2013 | 259 | 0.120 |
Why?
|
| Female | 7 | 2017 | 20969 | 0.120 |
Why?
|
| Cell Line | 1 | 2017 | 1354 | 0.110 |
Why?
|
| Cystatin B | 1 | 2013 | 7 | 0.110 |
Why?
|
| Disease Progression | 2 | 2013 | 601 | 0.110 |
Why?
|
| Rats, Transgenic | 1 | 2012 | 27 | 0.110 |
Why?
|
| Systole | 1 | 2012 | 61 | 0.110 |
Why?
|
| HIV-1 | 2 | 2022 | 706 | 0.110 |
Why?
|
| Puerto Rico | 1 | 2017 | 1378 | 0.100 |
Why?
|
| Stress, Mechanical | 1 | 2012 | 113 | 0.100 |
Why?
|
| Monocytes | 2 | 2013 | 257 | 0.100 |
Why?
|
| Electrocardiography | 1 | 2012 | 156 | 0.100 |
Why?
|
| Fibrosis | 1 | 2012 | 159 | 0.100 |
Why?
|
| Bisbenzimidazole | 1 | 2011 | 2 | 0.100 |
Why?
|
| Propidium | 1 | 2011 | 19 | 0.100 |
Why?
|
| Rhodamines | 1 | 2011 | 21 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2012 | 110 | 0.100 |
Why?
|
| Ribonucleases | 1 | 2011 | 30 | 0.100 |
Why?
|
| Limit of Detection | 1 | 2011 | 59 | 0.100 |
Why?
|
| Fluorescence | 1 | 2011 | 121 | 0.100 |
Why?
|
| Databases, Factual | 1 | 2012 | 291 | 0.100 |
Why?
|
| Action Potentials | 1 | 2012 | 231 | 0.090 |
Why?
|
| Adult | 4 | 2015 | 11712 | 0.090 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 208 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2017 | 1908 | 0.090 |
Why?
|
| Middle Aged | 3 | 2015 | 10129 | 0.090 |
Why?
|
| Myocardium | 1 | 2012 | 235 | 0.090 |
Why?
|
| Severity of Illness Index | 1 | 2012 | 610 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 2010 | 95 | 0.090 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 803 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1039 | 0.090 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 617 | 0.090 |
Why?
|
| Proteome | 1 | 2010 | 144 | 0.080 |
Why?
|
| Phosphorylation | 1 | 2012 | 928 | 0.080 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2008 | 11 | 0.080 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 252 | 0.080 |
Why?
|
| Models, Cardiovascular | 1 | 2008 | 49 | 0.080 |
Why?
|
| Antioxidants | 1 | 2010 | 416 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 219 | 0.060 |
Why?
|
| Mice | 2 | 2017 | 5913 | 0.060 |
Why?
|
| Male | 2 | 2012 | 20025 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2017 | 1198 | 0.050 |
Why?
|
| Cell Line, Tumor | 2 | 2017 | 2231 | 0.040 |
Why?
|
| Virus Replication | 1 | 2022 | 278 | 0.040 |
Why?
|
| Carbazoles | 1 | 2017 | 42 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2017 | 118 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2016 | 150 | 0.030 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 58 | 0.030 |
Why?
|
| Vitis | 1 | 2016 | 31 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2016 | 337 | 0.030 |
Why?
|
| Cell Cycle | 1 | 2016 | 326 | 0.030 |
Why?
|
| Neurons | 1 | 2022 | 1175 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2016 | 269 | 0.030 |
Why?
|
| Apoptosis | 1 | 2022 | 1398 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 864 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 571 | 0.030 |
Why?
|
| Viral Load | 1 | 2013 | 312 | 0.020 |
Why?
|
| Blood-Brain Barrier | 1 | 2013 | 162 | 0.020 |
Why?
|
| Immunologic Techniques | 1 | 2010 | 11 | 0.020 |
Why?
|
| Peroxiredoxins | 1 | 2010 | 9 | 0.020 |
Why?
|
| Chromatography, Affinity | 1 | 2010 | 67 | 0.020 |
Why?
|
| Peroxidase | 1 | 2010 | 49 | 0.020 |
Why?
|
| Thioredoxins | 1 | 2010 | 42 | 0.020 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 66 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2013 | 513 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2013 | 885 | 0.020 |
Why?
|
| United States | 1 | 2013 | 4223 | 0.010 |
Why?
|